12:00 AM
 | 
Jul 09, 2012
 |  BC Week In Review  |  Company News  |  Deals

Phenomenome, Polymedco deal

Polymedco received exclusive, U.S. commercialization rights to Phenomenome's gTA test. The companies submitted an application to FDA...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >